You cannot take semaglutide if you are already taking a different GLP-1 medication
Medication interactions are rare but not irrelevant
Early studies suggest that GLP-1 agonists, such as exenatide and liraglutide, may reduce breast cancer cell proliferation and viability by altering cellular energy metabolism
Possible symptoms of hypoglycemia to be aware of a rapid heartbeat shaking sweating dizziness or lightheadedness nervousness or anxiety irritability confusion Other side effects Some other potential side effects of semaglutide that require immediate medical attention include: persistent pain beginning in the upper left or middle of the abdomen, which may spread to the back skin rashes or hives swelling of the following areas: face, mouth, tongue, or throat legs, ankles, or feet difficulty breathing or swallowing decreased urination vision changes headache slurred speech shakiness or jitteriness weakness mood changes drowsiness Additional risks of compounded semaglutide Compared with FDA-approved semaglutide, compounded semaglutide poses more risks
Tirzepatide may cause side effects such as nausea, vomiting, diarrhea, constipation, fatigue, decreased appetite, and stomach discomfort
doi: 10.1021/acs.jafc.9b03092 170 WidmerRJFlammerAJLermanLOLermanA